How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Mobile Blood Collection Vehicles Market
- By Vehicle Type: Van-based Mobile Blood Collection Vehicles, Truck-based Mobile Blood Collection Vehicles, Bus-based Mobile Blood Collection Vehicles, Trailer-based Mobile Blood Collection Units
- By Blood Collection Method: Whole Blood Collection Units, Apheresis Collection Units, Plasma Collection Units
- By End User: Hospitals and Clinics, Blood Banks and Blood Centers, Government Health Agencies, Non-profit Organizations and Charitable Blood Drives
- By Vehicle Features: Refrigeration and Cold Storage Equipped Vehicles, Onboard Laboratory Testing Enabled Vehicles, Multipurpose Mobile Health Units with Blood Collection Capability
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Van-based Mobile Blood Collection Vehicles leads By Vehicle Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 270 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.160 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.168 →
Full report · locked preview
Everything inside the Mobile Blood Collection Vehicles Market report
A complete, evidence-based study - 11 chapters and 113 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Vehicle Type 4
Blood Collection Method 3
End User 4
Vehicle Features 3
Companies profiled
Fresenius Medical Care AG & Co. KGaA
Haemonetics Corporation
Terumo Corporation
Grifols
S.A.
Sartorius AG
Baxter International Inc.
Nipro Corporation
Macopharma
B. Braun Melsungen AG
HemaCare Corporation
Blood Systems Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Fresenius Medical Care AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Haemonetics Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Grifols
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Baxter International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Macopharma
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →HemaCare Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Blood Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Fenwal Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Cytiva (formerly GE Healthcare Life Sciences)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Ortho Clinical Diagnostics
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Miltenyi Biotec
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,591M by 2033 · 4.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Van-based Mobile Blood Collection Vehicles58.0
- Truck-based Mobile Blood Collection Vehicles15.4
- Bus-based Mobile Blood Collection Vehicles13.0
- Trailer-based Mobile Blood Collection Units13.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,749M → $2,501M · 4.6%
Europe$1,219M → $1,699M · 4.2%
Asia Pacific$1,113M → $1,646M · 5.0%
Latin America$689.2M → $899.9M · 3.4%
Middle East and Africa$530.1M → $781.8M · 5.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.542026
4.552027
4.562028
4.582029
4.592030
4.602031
4.612032
4.632033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Fresenius Medical Care AG & Co. KGaA24.6
- Haemonetics Corporation18.7
- Terumo Corporation6.2
- Grifols7.9
- S.A.4.3
- Sartorius AG10.3
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Vehicle Type17.2%
Blood Collection Method26.1%
End User27.7%
Vehicle Features29.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe22.6
- Asia Pacific21.9
- Latin America12.0
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 88 | 80 | 99 | 82 | 80 | 76 | 84 |
| Haemonetics Corporation | 68 | 83 | 79 | 71 | 68 | 91 | 77 |
| Terumo Corporation | 75 | 65 | 84 | 81 | 63 | 82 | 75 |
| Grifols | 57 | 71 | 81 | 78 | 70 | 63 | 70 |
| S.A. | 67 | 73 | 65 | 64 | 63 | 67 | 67 |
| Sartorius AG | 50 | 69 | 64 | 66 | 58 | 51 | 60 |
| Baxter International Inc. | 61 | 53 | 41 | 55 | 46 | 50 | 51 |
| Nipro Corporation | 58 | 52 | 46 | 43 | 47 | 48 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Fresenius Medical Care AG & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Haemonetics Corporation | − | ◐ | ✓ | − | ◐ | ✓ |
| Terumo Corporation | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| Grifols | − | − | ✓ | ✓ | ◐ | ◐ |
| S.A. | ◐ | ✓ | ◐ | − | ✓ | ◐ |
| Sartorius AG | − | ✓ | ◐ | − | ◐ | ◐ |
| Baxter International Inc. | ◐ | ◐ | − | − | − | ◐ |
| Nipro Corporation | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Fresenius Medical Care AG & Co. KGaA84
2Haemonetics Corporation77
3Terumo Corporation75
4Grifols70
5S.A.67
6Sartorius AG60
7Baxter International Inc.51
8Nipro Corporation49
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Fresenius Medical Care AG & Co. KGaA
Challenger4
Strong scale, closing on the leaders.
Haemonetics CorporationTerumo CorporationGrifolsS.A.
Contender1
Focused players with pockets of strength.
Sartorius AG
Niche2
Specialists in a single segment or region.
Baxter International Inc.Nipro Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Vehicle Type in North America, then scale across Mobile Blood Collection Vehicles Market — a $137M beachhead inside a $2.20B market.
Beachhead (SOM)$137Mobtainable near-term
Serviceable (SAM)$821Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Van-based Mobile Blood Collection Vehicles
Best fit — highest urgency & budget in Vehicle Type.
Economic buyer79 fit
Truck-based Mobile Blood Collection Vehicles
Strong fit — clear ROI and a fast path to value.
End user68 fit
Bus-based Mobile Blood Collection Vehicles
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Vehicle Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Blood Collection Method & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Vehicle Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Mobile Blood Collection Vehicles Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified21%
Evaluation12%
Closed-won6%
$8.2KCAC
$31KLTV
3.8:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Mobile Blood Collection Vehicles Market is a resilient opportunity — $4.56B by 2033, compounding at 5.2%.
TAM · 2025$3.05Btoday
TAM · 2033$4.56Bforecast
CAGR5.2%2027–2033
Cumulative$33.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.56BTotal addressable market
SAM$1.60BServiceable available market
SOM$331MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.2% CAGR
Demand compounds through 2033, outpacing GDP across Vehicle Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Vehicle Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.56BLarge & growingTAM by 2033 at 5.2% CAGR
$1.60BServiceable nowreachable with today’s model
$331MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.56BBear3.3% CAGR
$4.56BBase5.2% CAGR
$5.84BBull6.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Blood Collection Method optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Mobile Blood Collection Vehicles Market — a $3.01B market by 2033. Plan: grow share from 8.9% to 14.1%.
Market size · 2033$3.01Btotal addressable
Market CAGR9.5%2027–2033
Target share14.1%from 8.9% today
Revenue ambition$424Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.9% | 14.1% | On track |
| Revenue | $286M | $424M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 32.9% | 44.2% | On track |
| Customer retention | 88.9% | 93.3% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Vehicle Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Blood Collection Method capability
A defensible second engine — invest in Blood Collection Method to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Vehicle Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Blood Collection Method
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $58M capacity & capability investment
- Greenlight bolt-on M&A in Blood Collection Method
- Authorise North America expansion plan
- Fund R&D program for Vehicle Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Mobile Blood Collection Vehicles Market conversation — a $2.90B market you can size, segment and defend in minutes.
Market size · 2033$2.90Btotal opportunity
Growth3.5%CAGR to 2033
Addressable buyers1,507+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Vehicle Type
Goal Grow share in Vehicle Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 4 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Fresenius Medical Care AG & Co. KGaAHaemonetics CorporationTerumo CorporationGrifolsS.A.Sartorius AGBaxter International Inc.Nipro Corporation+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Mobile Blood Collection Vehicles Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Mobile Blood Collection Vehicles Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Mobile Blood Collection Service Market
Market size, share, segmentation and regional forecast.
$870M market · 2025 base year
View reportMobile Blood Bank Refrigerator Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportMobile Bedside X-ray Machine Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportMobile Audiology Van Market
Market size, share, segmentation and regional forecast.
$422M market · 2025 base year
View reportMobile Angiography Table Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportMobile Anesthesia Workstation Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportMobile Anesthesia Machines Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportMobile Anatomy Table Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportMobile 3D C-Arm X-Ray Machine Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportMMP13 Antibody Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportMKT-077 Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportMizolastine Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.